What is Biogen's long term notes payable?

Biogen (BIIB) reported long term notes payable of $6.29B in Q4 2025.

How has Biogen's long term notes payable changed year-over-year?

Biogen's long term notes payable increased by 38.3% year-over-year, from $4.55B to $6.29B.

What is the long-term trend for Biogen's long term notes payable?

Over 5 years (2020 to 2025), Biogen's long term notes payable has grown at a -3.5% compound annual growth rate (CAGR), from $7.50B to $6.29B.

What does long term notes payable mean?

Long-term debt obligations that are due for repayment after more than one year.

Discontinued — last reported Q3 '16

Other

Long Term Notes Payable

Biogen Long Term Notes Payable increased by 38.3% to $6.29B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 38.3%, from $4.55B to $6.29B. Over 5 years (FY 2020 to FY 2025), Long Term Notes Payable shows a downward trend with a -3.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLeverage

SignalLower is better

VolatilityStable

First reportedQ3 2015

Last reportedQ3 2016

How to read this metric

An increase indicates higher long-term borrowing to fund operations or acquisitions, while a decrease signals debt repayment or deleveraging.

Detailed definition

This represents the principal amount of debt obligations, excluding current maturities, that the company is contractuall...

Peer comparison

Standard for mature software companies; levels depend on capital structure and acquisition financing needs.

Metric ID: other_long_term_notes_payable

Historical Data

5 periods

	Q4 '21	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$7.57B	$6.28B	$6.79B	$4.55B	$6.29B
QoQ Change	—	-17.0%	+8.1%	-33.0%	+38.3%
YoY Change	—	-17.0%	+8.1%	-33.0%	+38.3%

Range$4.55B – $7.57B

CAGR-16.9%

Avg YoY Growth-0.9%

Median YoY Growth-4.5%

Frequently Asked Questions

What is Biogen's long term notes payable?: Biogen (BIIB) reported long term notes payable of $6.29B in Q4 2025.
How has Biogen's long term notes payable changed year-over-year?: Biogen's long term notes payable increased by 38.3% year-over-year, from $4.55B to $6.29B.
What is the long-term trend for Biogen's long term notes payable?: Over 5 years (2020 to 2025), Biogen's long term notes payable has grown at a -3.5% compound annual growth rate (CAGR), from $7.50B to $6.29B.
What does long term notes payable mean?: Long-term debt obligations that are due for repayment after more than one year.